What's new?

Sofinnova Partners Raises €472 ($548) Million to Form Largest Early-Stage Healthcare VC Fund in Europe

European venture capital firm has raised €1 billion in the last 12 months across its expanding life science investment platform PARIS, France – October 19,¬ 2021 - Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and Milan, announced today the close of its latest earl...

Avantium reaches key commercial milestone for its FDCA flagship plant with commitments for >50% of its output

AMSTERDAM, 7 April 2021, 18:00 hrs CEST – Avantium N.V., a leading technology company in renewable chemistry, announces that it has signed a conditional offtake agreement with Resilux, an international rigid plastic packaging supplier, for the supply of PEF resin from the planned Avantium FDCA flagship plant. This ...

Protera Appoints Novozymes Executive Thomas Videbaek As Chair of the Board of Directors and Non-Executive Board Member

SANTIAGO, CHILE and PARIS, FRANCE / ACCESSWIRE / April 6, 2021 / Protera, an AI-driven startup designing and developing new proteins to enable a wide range of natural and sustainable solutions, announced today it has appointed Novozymes senior executive Thomas Videbaek as Chair of the Board of Directors and non-exe...

ProQR Announces Positive Results from Clinical Trial of QR-421a in Usher Syndrome and Plans to Start Pivotal Trials

- QR-421a demonstrated a concordant benefit in multiple measures of vision, including best corrected visual activity (BCVA), static perimetry, and retinal imaging (OCT) - QR-421a observed to be well tolerated with no serious adverse events reported - Two pivotal Phase 2/3 trials are expected to start by the end of ...

Avantium secures new offtake contracts for planned FDCA flagship plant

Final Investment Decision Progress Update   AMSTERDAM, 24 March 2021, 07:00 CET – Avantium N.V., a leading technology company in renewable chemistry, announces that its subsidiary Avantium Renewable Polymers (“Avantium RNP”) has signed two additional conditional offtake agreements for the supply of PEF resin to man...

Inotrem Bolsters Leadership Team With the Appointment of Sven Zimmermann as New CEO

March 24, 2021 03:00 AM Eastern Daylight Time   PARIS--(BUSINESS WIRE)--Inotrem, an advanced clinical stage biotech company specialized in immunotherapies for acute and chronic inflammatory syndromes, announced today the appointment of Sven Zimmermann as Chief Executive Officer, effective April 19th, 2021. Sven bri...

Moon Surgical and King’s College London Announce Strategic Partnership to Develop Machine Learning for Computer-Assisted Surgery

King’s College London’s pioneering research in artificial intelligence & data analytics will strengthen Moon Surgical’s innovative Maestro platform Paris, London & San Francisco – March 23rd, 2021. Moon Surgical and King’s College London, School of Biomedical Engineering & Imaging Sciences, today announ...

Calliditas Announces Submission of New Drug Application to U.S. FDA for Nefecon in Patients with Primary IgA Nephropathy

STOCKHOLM, March 15, 2021/PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ:CALT, Nasdaq Stockholm: CALTX) ("Calliditas") today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Nefecon, a novel oral formulation targeting down regulation of IgA1 for the trea...

Abivax publishes data of ABX464 induction and long-term maintenance phase 2a ulcerative colitis study in the prestigious journal 'Gastroenterology'

Peer-reviewed article confirms the quality and robustness of clinical data and the good safety and durable efficacy of once daily oral ABX464 in moderate to severe ulcerative colitis (UC) patients Recruitment of subsequent phase 2b induction study in 254 patients with ABX464 in UC completed in December 2020 and top...

Mainstay Medical Announces US$108 Million Equity Financing Transaction

Funding to support U.S. commercial launch and global expansion   February 16, 2021 08:00 AM Eastern Standard Time - DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings plc (“Mainstay” or the “Company”) today announced the closing of an equity financing in which it raised gross proceeds of US$108 million. Mainstay in...

EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden

EnginZyme seeks to transform the $5 trillion chemical industry through the use of its enzyme-based platform, which combines the breadth and power of nature with the efficiencies of state-of-the-art chemical processing techniques   February 11, 2021 01:00 AM Eastern Standard Time STOCKHOLM--(BUSINESS WIRE)--EnginZym...

1 2 3 4 5 ... 11